On Friday at 2:00 PM, you have the chance to watch as Linda Persson, CEO of NanoEcho, presents the Q2 2024 report. The webcast presentation is organised by G&W Fondkommission.
On Friday at 2:00 PM, you have the chance to watch as Linda Persson, CEO of NanoEcho, presents the Q2 2024 report. The webcast presentation is organised by G&W Fondkommission.
NanoEcho’s innovative method, with its high precision, aims to facilitate the differentiation between diseased and healthy tissue and at the same time determine a more precise localization of cancerous tissue. The goal is to provide a more reliable diagnosis of, for example cancer diseases, that has the potential to contribute to cost-effectiveness in the health care.
We use cookies to enhance your experience on our website and analyze our traffic. By clicking ‘Accept,’ you consent to our use of cookies. You can learn more about the types of cookies we use and how to manage them in our privacy policy.